Aerami

Durham, United States Founded: 2010 • Age: 16 yrs
Therapeutics for cardiopulmonary diseases are developed using inhaled therapies.
Request Access

About Aerami

Aerami is a company based in Durham (United States) founded in 2010.. Aerami has raised $151.1 million across 13 funding rounds from investors including Molex and Molex Ventures. Aerami operates in a competitive market with competitors including MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia, among others.

  • Headquarter Durham, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $151.1 M (USD)

    in 13 rounds

  • Latest Funding Round
    $1.02 M (USD), Series B

    Nov 09, 2023

  • Investors
    Molex

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Aerami
Headcount 10-50
Employee Profiles 1
Board Members and Advisors 5
Employee Profiles
People
Anne Whitaker
Executive Chairwoman

Unlock access to complete

Board Members and Advisors
people
Steve Thornton
Director & Chair of Finance Committee

Unlock access to complete

Funding Insights of Aerami

Aerami has successfully raised a total of $151.1M across 13 strategic funding rounds. The most recent funding activity was a Series B round of $1.02 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 13
  • Last Round Series B — $1.0M
  • First Round

    (29 Dec 2014)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2023 Amount Series B - Aerami Valuation

investors

Dec, 2022 Amount Series B - Aerami Valuation

investors

Sep, 2021 Amount Series A - Aerami Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Aerami

Aerami has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Molex and Molex Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Communication equipment manufacturer
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Aerami

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Aerami

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aerami Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Aerami

Aerami operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MannKind Corp, OptiNose, Impel NeuroPharma, Alexza and Qnovia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of small-molecule drugs
domain founded_year HQ Location
Developer of smart devices for nasal drug delivery
domain founded_year HQ Location
Intranasal delivery technology for CNS diseases is developed.
domain founded_year HQ Location
Developer of products for the treatment of acute and intermittent conditions
domain founded_year HQ Location
Inhaled drug delivery devices are developed for pharmaceuticals.
domain founded_year HQ Location
Inhalation devices for medical applications are developed by Iconovo.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Aerami

When was Aerami founded?

Aerami was founded in 2010 and raised its 1st funding round 4 years after it was founded.

Where is Aerami located?

Aerami is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

Is Aerami a funded company?

Aerami is a funded company, having raised a total of $151.1M across 13 funding rounds to date. The company's 1st funding round was a Series A of $22.25M, raised on Dec 29, 2014.

What does Aerami do?

The company was founded in 2010 and is headquartered in Durham, United States. Operations center on the biotechnology sector, with a focus on inhaled therapeutics for severe respiratory conditions and related disorders. The pipeline includes AER-901 targeted at pulmonary arterial hypertension, AER-601 for post-prandial hyperglycemia, and AER-501 for type 1 and type 2 diabetes, among others. Development efforts address unmet needs in cardiopulmonary health.

Who are the top competitors of Aerami?

Aerami's top competitors include MannKind Corp, OptiNose and Impel NeuroPharma.

Who are Aerami's investors?

Aerami has 2 investors. Key investors include Molex, and Molex Ventures.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available